医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2021年第22届世界肺癌大会(WCLC)
     
 
 

◆ 会议时间:2021年9月8日至14日
◆ 会议地点:虚拟会议-Virtual


◆ 会议简介:

2021年第22届IASLC世界肺癌大会(WCLC2021)-虚拟会议将于2021年9月8日至14日举行,会议由国际肺癌研究协会(IASLC)主办。IASLC世界肺癌大会(WCLC)是世界上最大的致力于肺癌和其他胸部恶性肿瘤的多学科肿瘤学会议,每届都有来自全球100多个国家的7,000多名专业人士参会,共同探讨肺癌和其他胸部恶性肿瘤的最前沿治疗进展。 参会者包括外科医生、医学肿瘤学家、放射肿瘤学家、肺部学家、放射科医生、病理学家、流行病学家、基础研究科学家、护士和相关的卫生专业人员与患者代表。

国际肺癌研究协会(IASLC)是一个致力于肺癌研究的唯一的一家全球性组织。成立于1974年,由致力于肺癌领域研究的专家们发起和创立,该协会的会员包括100多个国家的5000多名肺癌专家。IASLC在肺癌的病因学、流行病学、预防、诊断、治疗以及所有与肺癌相关的领域开展深入研究,为医学团体与大众服务。——领域国际医学会议网翻译整理,未经本站允许,禁止复制、转载、镜像本站任何内容。

IASLC 2021 World Conference on Lung Cancer (WCLC2021)
September 8-14, 2021

Why attend WCLC 2021?

World's Largest
Join the world's largest international gathering of clinicians, researchers and scientists in the field of lung cancer and thoracic oncology.

Connect & Collaborate
Learn, share knowledge and network with over 5,000 delegates from more than 100 countries.

Exemplary Education
Benefit from wide-ranging and multidisciplinary content consisting of over 300 talks and 1,000+ poster presentations and 20 specialized tracks.

Extensive Resources
Choose from ground-breaking plenaries, experts lectures, research abstracts, as well as several sessions specifically dedicated to nurses, patients and advocates.

 

重要日期-Important Dates:

摘要-Abstracts

Call for Abstract Opens 点此提交摘要>>>Submit Abstract>>> March 8, 2021
Abstract Submission Deadline April 9, 2021 (23:59 PST)
Notification of Abstract Acceptance June 1, 2021
Late-Breaking Abstract Final Date Due July 10, 2021
Presentation Slides Submission Deadline July 23, 2021
Late-Breaking Abstract Notifications July 26, 2021
Presenting Author Registration Deadline July 30, 2021
Abstract Titles Release Date August 9, 2021
Full Abstract Release Date @ 18:00 EST
(Except for Embargoed Abstracts)
August 18, 2021
Poster Submission Deadline August 20, 2021

The Program Committee for the IASLC 2021 World Conference on Lung Cancer invites the submission of scientific abstracts. Authors are asked to submit abstracts under one of the following categories:

  • Early Stage/Localized Disease/Ablative Therapies
    Keywords: Neoadjuvant/ Adjuvant therapies, Early Stage, Minimally Invasive Surgery, Stage I, Stage II, Stereotactic Body Radiation Therapy
  • Global Health
    Keywords: Patterns of care, lower socioeconomic countries global health
  • Health Services Research/Health Economics
    Keywords: Health Policy, Cost Effectiveness, Quality of Care, Healthcare Access, Qualitative Research, Real-World Data, Observational Cohort Studies, Disease Registries And Databases, Artificial Intelligence, Machine Learning
  • Immuno-Biology and Novel Immunotherapeutics (Phase I and Translational)
    Keywords: Tumor Micro-environment, Bi-specific Ab, Vaccine Therapy, Cellular Therapy, Chimeric Antigen Receptors, Viroimmunotherapy, Cytokine Therapy, Translational Research, Check-Point Blockade Beyond PD-1/L1
  • Immunotherapy (Phase II/III Trials)
    Keywords: Phase II and III Clinical Trials, Immune Checkpoint Inhibitors, Randomised Controlled Trials, Biomarkers
  • Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    Keywords: Circulating Tumor Cells, Circulating Tumor DNA, Cell Free DNA, Circulating Cell-Free Noncoding RNAs, Circulating Exosomes, Liquid Biopsy, pleural effusion assays, urine based testing
  • Locally Advanced NSCLC
    Keywords: Chemoradiation, immunotherapy, surgical resection, tri-modality therapy,   neoadjuvant
  • Management of lung cancer in the era of COVID 19
    Keywords: Impact on care, complications, risk factors, impact on diagnosis and treatment
  • Mesothelioma, Thymoma and Other Thoracic Malignancies
    Keywords: Malignant Mesothelioma, Thymoma, Thymic Carcinoma, Thymic Epithelial Tumors, Oesophageal Cancer
  • Multimodality Management of Advanced Lung Cancer
    Keywords: Stereotactic Body Radiotherapy, Local Ablative Therapy, metastectomy, oligo-progression
  • Novel Therapeutics and Targeted Therapies
    Keywords: novel cytotoxics, phase I, pre-clinical, anti-body conjugates
  • Nursing and Allied Health Professionals
    Keywords: Rehabilitation, Physiotherapy, Survivorship Care
  • Palliative and Supportive Care
    Keywords: Palliative care, Decision-making, Decision Support Techniques, Ethics, Quality of Life, Integrative care
  • Patient Advocacy 
    Keywords: Survivorship, Advocacy, Community Outreach, Patient-driven Research, Advocacy Foundations, Patient Advocacy, Patient Reported Outcomes, Lung Cancer Stigma
  • Predicative Tumor Based Assays/Biomarkers/Pathology
    Keywords: tumor microenvironment, IHC. FISH, NGS, tissue diagnostics, novel tumor
  • Risk Reduction and Tobacco Control
    Keywords: Tobacco Control Policy, Tobacco Prevention Patient, Framework Convention on Tobacco Control, Smoking Cessation, Radon, Bio Mass, Environmental
  • Screening and Early Detection
    Keywords: Screening, Early Detection, Low Dose Spiral CT Scan, Early Diagnosis, Exhaled Air, Pulmonary Nodule, GGO, Biomarkers For Early Detection, Risk Models, Nodule Evaluation, Artificial Intelligence For Early Detection, Radiomics
  • Small Cell Lung Cancer/NET
    Keywords: Small Cell Lung Cancer, Neuroendocrine Tumours, Atypical Carcinoid
  • Staging/Pulmonary Medicine
    Keywords: Staging, Tumor Size Characteristics, Node Characteristics, Metastatic Characteristics, IASLC Staging System
  • Tumor Biology and Systems Biology – Basic and Translational Science
    Keywords: Tumor Biology, Mouse Models, Basic Science, Translational Science, Bioinformatics, Transcriptomics and other novel omics,

 


 

Dear Colleagues and Friends, Sponsors and Exhibitors,

Considering the ongoing concerns caused by COVID-19, the IASLC decided to transition all of its 2021 live conferences to worldwide virtual events, including the next World Conference on Lung Cancer 2021 so you can experience the Conference from the comfort and safety of your home or office.

The IASLC continues to monitor the situation on an ongoing basis. If public health circumstances allow, the IASLC may also offer in-person opportunities if feasible. Our primary goal is to ensure that educational and scientific content is available to all interested participants, while protecting the health and well-being of attendees and faculty.

We are working on a new virtual experience that will be both, interesting and engaging. Join us virtually from September 8 – 14, 2021. We are planning for more but shorter days full of practice-changing science.

The IASLC is committed to offering quality experiences that continue to provide opportunities for attendee engagement that have been a hallmark of the IASLC’s in-person conferences. The IASLC will continue to deliver on its fundamental mission by bringing critical education in all aspects of thoracic cancer to the widest possible audience. In addition to Plenary and Educational Sessions, the program will feature a full day of audience and regional targeted workshops.

We recognize that many of our global and multidisciplinary members and meeting attendees are healthcare workers who are on the front line of studying, diagnosing and treating lung cancer. We want to express our gratitude and admiration to you and to all health care professionals working in incredibly difficult circumstances to contain this outbreak and prevent further loss of life.

We hope to see you online or perhaps in person from September 8 – 14. Even if we are physically apart, we are still together as a community, connected by a shared passion for conquering thoracic cancers and malignancies worldwide and for the best outcomes for our patients.

Sincerly,

David Harpole,
IASLC WCLC 2021
Conference President
Kristin Higgins,
IASLC WCLC 2021
Conference Co-Chair
Thomas A. Stinchcombe,
IASLC WCLC 2021
Conference Co-Chair

 


 

WCLC 2021 注册费:

Early Registration Deadline: July 30, 2021 (23:59 PST)

Full Conference Registration
IASLC Member
USD 195
Regular USD 315
Non-Member
USD 315
Regular USD 440

Fellows, Students & Trainees

IASLC Member
USD 70
Regular USD 125
Non-Member
USD 90
Regular USD 170

Registered Nurses & Allied Health Professionals

IASLC Member
USD 70
Regular USD 125
Non-Member
USD 90
Regular USD 170

Developing Nations

IASLC Member
USD 70
Regular USD 125
Non-Member
USD 90
Regular USD 170

Patient Advocates

IASLC Member
USD 40
Regular USD 105
Non-Member
USD 85
Regular USD 145

Patients/Caregiver

 
Complimentary  

Registration Cancellation Policy

Registration cancellations received via email at the IASLC WCLC 2020 Conference Secretariat’s address on or before August 20, 2021 (23:59 PST) will be accepted and all fees refunded, less a USD 50.00 administrative fee, as per Committee policy. Cancellations received August 20, 2021 (23:59 PST) will not be refunded. However, transfer of your registration to another person is permitted by re-accessing the original delegate’s registration information via the confirmation letter and replacing it with the new delegate’s information. No refunds will be made for non-attendance at the Conference.

Donations to the International Lung Cancer Foundation are non-refundable.

 


2021年世界肺癌大会WCLC2021-IASLC世界肺癌大会-国际肺癌研究协会世界肺癌大会IASLC-WCLC


◆ 参会对象:
诊断和治疗肺癌患者的医疗保健专业人士,包括临床医生,肿瘤内科医生,科学家,胸外科医生,呼吸科/肺科医师,放射肿瘤学家,放射学家,病理学家,介入放射科医师,基础研究科学家、流行病学家以及高级执业护士和医师助手,以及其他相关专业人士代表。

 
 
※相关服务※
会议注册服务:50美金/人/次 + 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1500元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 免责声明及隐私政策 | 联系我们